Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$2.24 - $4.29 $1.12 Million - $2.15 Million
-500,256 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$4.39 - $7.23 $6,510 - $10,722
-1,483 Reduced 0.3%
500,256 $2.2 Million
Q1 2021

May 13, 2021

SELL
$4.39 - $9.08 $52,952 - $109,522
-12,062 Reduced 2.35%
501,739 $3.64 Million
Q4 2020

Feb 12, 2021

BUY
$3.86 - $5.07 $36,623 - $48,104
9,488 Added 1.88%
513,801 $2.22 Million
Q3 2020

Nov 12, 2020

SELL
$4.11 - $6.45 $50,914 - $79,902
-12,388 Reduced 2.4%
504,313 $2.07 Million
Q2 2020

Aug 11, 2020

BUY
$5.75 - $11.99 $105,282 - $219,536
18,310 Added 3.67%
516,701 $3.1 Million
Q1 2020

May 14, 2020

SELL
$5.65 - $15.71 $65,472 - $182,047
-11,588 Reduced 2.27%
498,391 $3.75 Million
Q4 2019

Feb 13, 2020

BUY
$10.15 - $15.58 $1,542 - $2,368
152 Added 0.03%
509,979 $7.01 Million
Q3 2019

Nov 05, 2019

SELL
$11.88 - $16.72 $23,439 - $32,988
-1,973 Reduced 0.39%
509,827 $6.06 Million
Q2 2019

Aug 14, 2019

BUY
$13.2 - $20.63 $928,976 - $1.45 Million
70,377 Added 15.94%
511,800 $7.16 Million
Q1 2019

May 13, 2019

SELL
$12.01 - $19.49 $3,542 - $5,749
-295 Reduced 0.07%
441,423 $7.89 Million
Q4 2018

Feb 08, 2019

BUY
$12.4 - $18.7 $5.48 Million - $8.26 Million
441,718 New
441,718 $6.95 Million

Others Institutions Holding ORTX

About Orchard Therapeutics plc


  • Ticker ORTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,458,000
  • Description
  • Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...
More about ORTX
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.